These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 25913567)

  • 1. Reply to the comment by de Boer and Hoppentocht on: inhaled antimicrobial therapy - barriers to effective treatment, by J. Weers, Adv. Drug Deliv. Rev. (2015), http://dx.doi.org/10.1016/j.addr.2014.08.013.
    Weers J
    Adv Drug Deliv Rev; 2015 May; 85():e3-5. PubMed ID: 25913567
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to the comment by Cipolla et al. on: inhaled antimicrobial therapy--barriers to effective treatment, by J. Weers, Adv. Drug Deliv. Rev. (2015), http://dx.doi.org/10.1016/j.addr.2014.08.013.
    Weers J
    Adv Drug Deliv Rev; 2015 May; 85():e8-e10. PubMed ID: 25913566
    [No Abstract]   [Full Text] [Related]  

  • 3. Comment on: inhaled antimicrobial therapy--barriers to effective treatment, by J. Weers, inhaled antimicrobial therapy - barriers to effective treatment, Adv. Drug Deliv. Rev. (2015), http://dx.doi.org/10.1016/j.addr.2014.08.013.
    Cipolla D; Froehlich J; Gonda I
    Adv Drug Deliv Rev; 2015 May; 85():e6-7. PubMed ID: 25913564
    [No Abstract]   [Full Text] [Related]  

  • 4. Comment on: inhaled antimicrobial therapy-Barriers to effective treatment, by J.Weers, Adv. Drug Deliv. Rev. (2014), http://dx.doi.org/ 10.1016/j.addr.2014.08.013.
    de Boer AH; Hoppentocht M
    Adv Drug Deliv Rev; 2015 May; 85():e1-2. PubMed ID: 25913565
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhaled antimicrobial therapy - barriers to effective treatment.
    Weers J
    Adv Drug Deliv Rev; 2015 May; 85():24-43. PubMed ID: 25193067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary drug delivery systems for antimicrobial agents: facts and myths.
    Falagas ME; Michalopoulos A; Metaxas EI
    Int J Antimicrob Agents; 2010 Feb; 35(2):101-6. PubMed ID: 19939637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaled anti-infective chemotherapy for respiratory tract infections: successes, challenges and the road ahead.
    Velkov T; Abdul Rahim N; Zhou QT; Chan HK; Li J
    Adv Drug Deliv Rev; 2015 May; 85():65-82. PubMed ID: 25446140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled formulations and pulmonary drug delivery systems for respiratory infections.
    Zhou QT; Leung SS; Tang P; Parumasivam T; Loh ZH; Chan HK
    Adv Drug Deliv Rev; 2015 May; 85():83-99. PubMed ID: 25451137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial resistance--fluoroquinolones and the tiger's tail.
    Tillotson GS; Carroll J; Klugman KP
    J Chemother; 2006 Jun; 18(3):328-30. PubMed ID: 17129847
    [No Abstract]   [Full Text] [Related]  

  • 10. Novel agents for the treatment of outpatient respiratory tract infections. Introduction.
    Pell DM
    Postgrad Med; 2002 Sep; 112(3 Suppl):5-6. PubMed ID: 19667592
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhaled Antibiotics for Ventilator-Associated Infections.
    Palmer LB
    Infect Dis Clin North Am; 2017 Sep; 31(3):577-591. PubMed ID: 28779834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery of antibiotics to the respiratory tract: an update.
    Traini D; Young PM
    Expert Opin Drug Deliv; 2009 Sep; 6(9):897-905. PubMed ID: 19637984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guidelines for antimicrobial therapy of acute upper respiratory tract infections in Taiwan.
    J Microbiol Immunol Infect; 2002 Dec; 35(4):272-3. PubMed ID: 12542257
    [No Abstract]   [Full Text] [Related]  

  • 14. Drugs for bacterial infections.
    Treat Guidel Med Lett; 2010 Jun; 8(94):43-52. PubMed ID: 20489679
    [No Abstract]   [Full Text] [Related]  

  • 15. Antimicrobial drugs in the treatment of respiratory infections.
    Sen P
    J Indian Med Assoc; 1979 Jul; 73(1):18-20. PubMed ID: 536598
    [No Abstract]   [Full Text] [Related]  

  • 16. From macrolides to ketolides: What is available for the treatment of outpatient respiratory tract infections?
    Carter PL
    Postgrad Med; 2002 Sep; 112(3 Suppl):18-25. PubMed ID: 19667591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of carbapenems in the treatment of severe nosocomial respiratory tract infections.
    Joseph J; Rodvold KA
    Expert Opin Pharmacother; 2008 Mar; 9(4):561-75. PubMed ID: 18312158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled antibiotics for gram-negative respiratory infections.
    Hudson R; Olson Blair B
    Future Med Chem; 2011 Oct; 3(13):1663-77. PubMed ID: 21942255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Respiratory infections and antimicrobial therapy.
    Saunders WH
    Otolaryngol Clin North Am; 1970 Jun; 3(2):303-17. PubMed ID: 5006503
    [No Abstract]   [Full Text] [Related]  

  • 20. Combating antimicrobial resistance: quality standards for prescribing for respiratory infections in Vietnam.
    Li R; van Doorn HR; Wertheim HFL; Khue LN; Ha NTB; Dat VQ; Hanh CT; Nga DTT; Trang NNM; Nadjm B; Cluzeau F; Kinh NV; Trung NV; Huong NTL; Chau NQ; Huong Q; Thao LT; Hong LTA; Oanh TTM; Islam J; Roberts CM; Chalkidou K
    Lancet Glob Health; 2016 Nov; 4(11):e789. PubMed ID: 27765287
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.